The Defense Threat Reduction Agency's Chemical and Biological Technologies Department will host the 2017 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Nov. 28-30, 2017, in Long Beach, Calif.
Schematic of integrated liver, heart and lung models interconnected by microfluidic devices that simulate the human circulatory system. (Graphic courtesy of Dr. Anthony Atala, Wake Forest Institute for Regenera More
A number of DNA vaccine delivery devices are in commercial development which have the potential to overcome these logistical burdens. Several of them will be evaluated by medical personnel at the Delivery of Nu More
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical More
Collaboration between Defense Threat Reduction Agency, Chemical and Biological Technologies Department and Wake Forest Institute for Regenerative Medicine resulted in developing organ-on-a-chip technology. The More
Dr. Hann, Director of the Joint Science and Technology Office at the Defense Threat Reduction Agency, examines the liver module of the XCEL project at Los Alamos National Laboratory.